Pregnancy outcomes in systemic lupus erythematosus: experience from a Caribbean center

References

• Khan A, Thomas M, P. K SD. Pregnancy complicated by systemic lupus erythematosus and its outcome over 10 years. J Obstet Gynaecol. 2018;38(4):476–481.
   PubMedGoogle Scholar
• Chambers S, Raine R, Rahman A, et al. Factors influencing adherence to medications in a group of patients with systemic lupus erythematosus in Jamaica. Lupus. 2008;17(8):761–769.
   PubMed Web of Science ®Google Scholar
• Wilson WA, Hughes GR. Rheumatic disease in Jamaica. Ann Rheum Dis. 1979;38(4):320–325.
   PubMed Web of Science ®Google Scholar
• Soyibo A, DeCuelaer K, Miller R, et al. Establishing the Jamaica lupus registry: report of patients with systemic lupus erythematosus attending a major referral hospital in Jamaica. West Indian Med J. 2012;61(3):249–253.
   PubMed Web of Science ®Google Scholar
• Flower C, Hennis AJM, Hambleton IR, et al. Systemic lupus erythematosus in an african caribbean population: incidence, clinical manifestations, and survival in the Barbados national lupus registry. Arthritis Care Res. 2012;64:1151–1158.
   PubMed Web of Science ®Google Scholar
• Kaplowitz ET, Ferguson S, Guerra M, et al. Contribution of socioeconomic status to racial/ethnic disparities in adverse pregnancy outcomes among women with systemic lupus erythematosus. Arthritis Care Res. 2018;70(2):230–235.
   Web of Science ®Google Scholar
• Shen G, Swaminathan M, Huang I, et al. Racial disparities in pregnancy outcomes among women with rheumatic diseases: a systematic literature review. Semin Arthritis Rheum. 2023;60:152193.
   PubMed Web of Science ®Google Scholar
• Polić A, Običan SG. Pregnancy in systemic lupus erythematosus. Birth Defects Res. 2020;112(15):1115–1125.
   PubMedGoogle Scholar
• Di Mario C, Petricca L, Gigante MR, et al. Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: influence of the disease severity and therapy on the ovarian reserve. Endocrine. 2019;63(2):369–375.
   PubMed Web of Science ®Google Scholar
• Zhang S, Han X, Liu W, et al. Pregnancy in patients with systemic lupus erythematosus: a systematic review. Arch Gynecol Obstet. 2022. DOI:10.1007/s00404-022-06718-7
   Web of Science ®Google Scholar
• Do SC, Druzin ML. Systemic lupus erythematosus in pregnancy: high risk, high reward. Curr Opin Obstet Gynecol. 2019;31(2):120–126.
   PubMed Web of Science ®Google Scholar
• Buyon JP, Kim MY, Guerra MM, et al. Predictors of pregnancy outcomes in patients with lupus: a cohort study. Ann Intern Med. 2015;163(3):153–163.
   PubMed Web of Science ®Google Scholar
• Marder W. Update on pregnancy complications in systemic lupus erythematosus. Curr Opin Rheumatol. 2019;31(6):650–658.
   PubMed Web of Science ®Google Scholar
• Lau CS, Yin G, Mok MY. Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus. 2006;15(11):715–719.
   PubMed Web of Science ®Google Scholar
• Gohr M, Jakobsen IM, Helmig RB, et al. Improved pregnancy outcomes in systemic lupus erythematosus: a retrospective study of pregnancies from a single Centre in Denmark from 2010–2020 compared with the period 1990–2010. Lupus. 2022;31(10):1202–1210.
   PubMed Web of Science ®Google Scholar
• Ideguchi H, Ohno S, Uehara T, et al. Pregnancy outcomes in japanese patients with SLE: retrospective review of 55 pregnancies at a university hospital. Clin Rev Allergy Immunol. 2013;44(1):57–64.
   PubMed Web of Science ®Google Scholar
• Nwokocha M, Romero CA, Holder C, et al. Blood pressure screening campaign in Jamaica: may measurement month 2017. Am J Hypertens. 2019;32(12):1186–1191.
   PubMed Web of Science ®Google Scholar
• Kasturi S, Sammaritano LR. Corticosteroids in lupus. Rheum Dis Clin North Am. 2016;42(1):47–62, viii.
   PubMed Web of Science ®Google Scholar
• Lunghi L, Pavan B, Biondi C, et al. Use of glucocorticoids in pregnancy. Curr Pharm Des. 2010;16(32):3616–3637.
   PubMed Web of Science ®Google Scholar
• Cai E, Czuzoj-Shulman N, Abenhaim HA. Maternal and fetal outcomes in pregnancies with long-term corticosteroid use. J Mat-Fetal Neonatal Med. 2021;34(11):1797–1804.
   PubMed Web of Science ®Google Scholar
• Carmichael SL, Shaw GM, Ma C, et al. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol. 2007;197(6):585.e1–7.
   PubMed Web of Science ®Google Scholar
• Monzavi SM, Alirezaei A, Shariati-Sarabi Z, et al. Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers. Inflammopharmacol. 2018;26(5):1175–1182.
   PubMed Web of Science ®Google Scholar
• Seo MR, Chae J, Kim YM, et al. Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia. Lupus. 2019;28(6):722–730.
   PubMed Web of Science ®Google Scholar
• Bermas BL, Kim SC, Huybrechts K, et al. Trends in use of hydroxychloroquine during pregnancy in systemic lupus erythematosus patients from 2001 to 2015. Lupus. 2018;27(6):1012–1017.
   PubMed Web of Science ®Google Scholar
• Aringer M, Leuchten N, Johnson SR. New criteria for lupus. Curr Rheumatol Rep. 2020;22(6):18.
   PubMed Web of Science ®Google Scholar
• Aringer M. EULAR/ACR classification criteria for SLE. Semin Arthritis Rheum. 2019;49(3S):S14–S17.
   PubMedGoogle Scholar
• Kim J-W, Jung J-Y, Kim H-A, et al. Lupus low disease activity state achievement is important for reducing adverse outcomes in pregnant patients with systemic lupus erythematosus. J Rheumatol. 2021;48(5):707–716.
   PubMed Web of Science ®Google Scholar
• Murata T, Kyozuka H, Fukuda T, et al. Maternal disease activity and serological activity as predictors of adverse pregnancy outcomes in women with systemic lupus erythematosus: a retrospective chart review. Arch Gynecol Obstet. 2022;305(5):1177–1183.
   PubMed Web of Science ®Google Scholar
• Wu J, Ma J, Zhang W-H, et al. Management and outcomes of pregnancy with or without lupus nephritis: a systematic review and meta-analysis. Ther Clin Risk Manag. 2018;14:885–901.
   PubMed Web of Science ®Google Scholar
• Balow JE. Clinical presentation and monitoring of lupus nephritis. Lupus. 2005;14(1):25–30.
   PubMed Web of Science ®Google Scholar
• Saha MK, Massicotte-Azarniouch D, Reynolds ML, et al. Glomerular hematuria and the utility of urine microscopy: a review. American J Kidney Dis. 2022;80 (3):383–392.
   PubMed Web of Science ®Google Scholar
• Peart E, Clowse MEB. Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature. Curr Opin Rheumatol. 2014;26(2):118–123.
   PubMed Web of Science ®Google Scholar
• Zamani B, Shayestehpour M, Esfahanian F, et al. The study of factors associated with pregnancy outcomes in patients with systemic lupus erythematosus. BMC Res Notes. 2020;13(1):185.
   PubMed Web of Science ®Google Scholar
• Hussein E, Riyad R, Mokbel A. Pregnancy outcome in patients with systemic lupus erythematosus: a single center study in the high risk pregnancy unit. Middle East Fertility Society Journal. 2016;21:168–174.
   Google Scholar
• Chen K, Lin Q, Wu J. Science & technology on public health in China: A Roadmap 2050. (Chinese Academy Of Sciences) [PDF] [1n1elhatcisg] [Internet]. [cited 2022 Jun 2]. Available from: https://vdoc.pub/documents/science-technology-on-public-health-in-china-a-roadmap-to-2050-chinese-academy-of-sciences-1n1elhatcisg.
   Google Scholar
• He WR, Wei H. Maternal and fetal complications associated with systemic lupus erythematosus. Medicine. 2020;99(16):e19797.
   PubMed Web of Science ®Google Scholar
• Nelson-Piercy C. Handbook of obstetric Medicine - Sixth edition. 6th ed. 6000 broken sound parkway NW, suite 300., Boca Raton, FL 33487-2742: CRC Press; 2021.
   Google Scholar
• Ray JG, Wanigaratne S, Park AL, et al. Preterm preeclampsia in relation to country of birth. J Perinatol. 2016;36(9):718–722.
   PubMed Web of Science ®Google Scholar
• Janardana R, Haridas V, Priya V, et al. Maternal and fetal outcomes of lupus pregnancies: a collective effort by Karnataka rheumatologists. Lupus. 2020;29(11):1397–1403.
   PubMed Web of Science ®Google Scholar
• Chen C-Y, Chen Y-H, Lin H-C. Increased risk of adverse pregnany outcomes for hospitalisation of women with lupus during pregnancy a nation wide population-based study. Clin Exp Rheumatol. 2010;28(1):49–55.
   PubMed Web of Science ®Google Scholar
• Baer AN, Witter FR, Petri M. Lupus and pregnancy. Obstet Gynecol Surv. 2011;66(10):639–653.
   PubMed Web of Science ®Google Scholar
• Kroese SJ, de Hair MJH, Limper M, et al. Hydroxychloroquine use in lupus patients during pregnancy is associated with longer pregnancy duration in preterm births. J Immunol Res. 2017;2017:e2810202.
   PubMed Web of Science ®Google Scholar
• Broder A, Mowrey WB, Valle A, et al. Prescribing patterns of hydroxychloroquine and corticosteroids among lupus patients after new‐onset end‐stage renal disease. Arthritis Care Res. 2022;74(12):2024–2032.
   Web of Science ®Google Scholar
• Haase I, Chehab G, Sander O, et al. Ab0341 sle pregnancies at high risk for pre-eclampsia benefit most from combination of low dose aspirin and hydroxychloroquine. Ann Rheum Dis. 2021;80(Suppl 1):1195.2–1196.
   Google Scholar
• Mayer-Pickel K, Kolovetsiou-Kreiner V, Stern C, et al. Effect of low-dose aspirin on soluble FMS-like tyrosine kinase 1/placental growth factor (sFlt-1/PlGF ratio) in pregnancies at high risk for the development of preeclampsia. JCM. 2019;8(9):1429.
   Google Scholar
• Schramm AM, Clowse MEB. Aspirin for prevention of preeclampsia in lupus pregnancy. Autoimmune Dis. 2014;2014:920467.
   PubMedGoogle Scholar